Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
China Isotope & Radiation Corp. ( (HK:1763) ) has provided an update.
China Isotope & Radiation Corporation announced its annual financial results for the year ended December 31, 2024, showing a significant increase in revenue and profit compared to the previous year. The company’s revenue rose to RMB 7.57 billion, with a gross profit of RMB 3.68 billion, reflecting strong operational performance and market demand, which positively impacts its industry positioning and stakeholder interests.
More about China Isotope & Radiation Corp.
China Isotope & Radiation Corporation is a joint stock company incorporated in the People’s Republic of China, operating in the isotope and radiation industry. The company focuses on providing products and services related to isotopes and radiation technologies, catering to various market needs in this specialized sector.
YTD Price Performance: 19.71%
Average Trading Volume: 169,373
Technical Sentiment Signal: Sell
Current Market Cap: HK$4.16B
Find detailed analytics on 1763 stock on TipRanks’ Stock Analysis page.